Suppr超能文献

临床实践中的乳糜泻诊断:来自28个国家129家儿科医院的ESPGHAN医疗质量调查

Celiac disease diagnosis in clinical practice: ESPGHAN quality of care survey from 129 pediatric hospitals across 28 countries.

作者信息

Litwin Anna, Le Thi Thu Giang, El-Lababidi Nabil, Kindermann Angelika, Pancheva Rouzha, Gerasimidis Konstantinos, Goncalves Cristina Campos, Escobar Paula Crespo, Niseteo Tena, Ikrath Katharina, Koletzko Sibylle

机构信息

Department of Pediatrics, Division of Pediatric Gastroenterology and Hepatology, Dr. von Hauner Children's Hospital, LMU University Hospital Munich, LMU Munich, Munich, Germany.

Stiftung Kindergesundheit, c/o Dr. von Hauner Children's Hospital, LMU University Hospital Munich, LMU Munich, Munich, Germany.

出版信息

J Pediatr Gastroenterol Nutr. 2025 Sep;81(3):606-617. doi: 10.1002/jpn3.70143. Epub 2025 Jul 7.

Abstract

OBJECTIVES

European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) guidelines recommend first-line serology for suspected celiac disease (CeD), measuring only transglutaminase antibodies (TGA-immunoglobulin A [IgA]) plus total IgA. If TGA-IgA is ≥10 times the normal value, pediatric gastroenterologists (pedGI) may diagnose CeD without biopsies if autoantibodies against endomysial antibodies (EMA-IgA) are positive in a 2nd blood sample. This Quality-of-Care (QoC) project benchmarked diagnostic workup in clinical practice using ESPGHAN CeD guidelines as reference.

METHODS

A pseudonymized survey on CeD practices was sent to 141 hospitals within the ESPGHAN QoC-network in 28 countries.

RESULTS

Questionnaires were completed by 129/141 (91.5%) hospitals, with 121 (94%) having pedGI staff. As reasons conflicting with good QoC for CeD in their setting, responders assumed knowledge deficits among the public (57%), primary care providers (64%), non-GI physicians (16%), and pedGIs (0%). For initial testing, 66% of physicians ordered only total IgA and TGA-IgA, 7% did not use this combination, and 29% ordered additional serology (TGA-IgG, EMA, antibodies against deaminated gliadin peptide, or native gliadin). Regarding conflicting results for TGA-IgA and histopathology in IgA-sufficient children, 61% incorrectly classified negative TGA-IgA with Marsh 2 and 57% with Marsh 3 lesions as "potential CeD," while 49% excluded CeD in the case of villous atrophy and negative TGA-IgA. Routine practice did not align with the ESPGHAN recommendations regarding performance of duodenal biopsies (27%), EMA-testing (34%), and diagnosis of CeD in IgA-deficient children (32%).

CONCLUSIONS

We identified areas for improving QoC regarding both effectiveness and efficacy, in pediatric patients with suspected CeD, and consequently developed easy-to-use tools to improve guideline implementation.

摘要

目的

欧洲儿科胃肠病、肝病和营养学会(ESPGHAN)指南推荐,对于疑似乳糜泻(CeD)患者,一线血清学检测仅测定转谷氨酰胺酶抗体(TGA - 免疫球蛋白A [IgA])加总IgA。如果TGA - IgA≥正常值的10倍,若第二次血样中抗肌内膜抗体(EMA - IgA)呈阳性,儿科胃肠病专家(pedGI)可不进行活检诊断CeD。本医疗质量(QoC)项目以ESPGHAN CeD指南为参考,对临床实践中的诊断检查进行了基准评估。

方法

向28个国家的ESPGHAN QoC网络内的141家医院发送了关于CeD诊疗实践的匿名调查问卷。

结果

129/141(91.5%)家医院完成了问卷,其中121家(94%)有pedGI工作人员。作为其所在机构中与CeD良好QoC相冲突的原因,受访者认为公众(57%)、初级保健提供者(64%)、非胃肠病医生(16%)和pedGI(0%)存在知识欠缺。对于初始检测,66%的医生仅开具总IgA和TGA - IgA,7%未使用该组合,29%开具了额外的血清学检测(TGA - IgG、EMA、抗脱酰胺麦醇溶蛋白肽抗体或天然麦醇溶蛋白抗体)。关于IgA充足儿童中TGA - IgA与组织病理学结果冲突的情况,61%将Marsh 2型和57%将Marsh 3型病变中TGA - IgA阴性错误分类为“潜在CeD”,而49%在绒毛萎缩且TGA - IgA阴性的情况下排除CeD诊断。常规实践在十二指肠活检的操作(27%)、EMA检测(34%)以及IgA缺乏儿童的CeD诊断(32%)方面与ESPGHAN建议不一致。

结论

我们确定了在疑似CeD的儿科患者中提高QoC的有效性和效率方面的改进领域,并因此开发了易于使用的工具以改善指南的实施。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验